Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64950, first published .
Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Zhiqiang Gao   1 , MD, PhD ;   Jiajun Teng   1 , MD, PhD ;   Rong Qiao   1 , MD, PhD ;   Jialin Qian   1 ;   Feng Pan   1 , MD, PhD ;   Meili Ma   1 , MD, PhD ;   Jun Lu   1 , MD, PhD ;   Bo Zhang   1 ;   Tianqing Chu   1 , MD, PhD ;   Hua Zhong   1 , MD, PhD

1 Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Corresponding Author:

  • Hua Zhong, MD, PhD
  • Shanghai Chest Hospital
  • Shanghai Jiao Tong University School of Medicine
  • 241 Huaihai West Road
  • Xuhui District
  • Shanghai
  • China
  • Phone: 86 02122200000
  • Email: zhonghua_gcp@163.com